Newly announced regenerative solutions for arthritis pain from Elevated Medicine (+1 855 589 4443) include orthobiologic ...

Ultracentrifugal analyses revealed a fall in the percentage of 18 S macroglobulin from 64 to 34 † Cardiac catheterizations were performed by Drs. Samuel Fox and Thomas Lynn, National Heart ...

Background: Atrial fibrillation (AF) is the most common cardiac arrhythmia, significantly increasing the risk of death and stroke. The left atrial appendage (LAA) plays a crucial role in the ...

CYT-108 is a recombinant variant of the alpha-2-macroglobulin blood serum protease inhibitor. The company commenced the Phase I clinical trial of a CYT-108 for osteoarthritis of the knee in July this ...

Researchers created a Modified Staging System for Waldenström macroglobulinemia that could improve risk stratification for treatment-naïve patients. Outcomes for Waldenström macroglobulinemia (WM) are ...

ABBV-101 is under clinical development by AbbVie and currently in Phase I for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma). According to GlobalData, Phase I drugs for Waldenstrom ...